// App-Quantinova.ai

OC 51.2 : Changes in VWF, ADAMTS13, and Complement in Preeclampsia, HELLP syndrome and Other Obstetric Complications: a Single Centre Observational Study.

Researchers

Presenter

  • L. Neave

Principal Investigators

  • M. Thomas

  • A. Doyle

  • A. David

  • M. Whitten

  • M. Scully

Medical Centers

  • UCLH Hospitals NHS Trust / Haemostasis Research Unit, University College London, London, England, United Kingdom

  • University College Hospitals London NHS Foundation Trust, London, England, United Kingdom

  • Kings College London, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Elizabeth Garrett Anderson Institute for Women's Health, Univerisity College London, London, England, United Kingdom

  • Fetal Medicine Unit, UCLH Hospitals NHS Trust /Institute for Women's Health, University College London, London, England, United Kingdom

  • Elizabeth Garrett Anderson Institute for Women's Health, London, England, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Obstetrics/Gynecology

Disease

  • HELLP syndrome

  • Preeclampsia

Biomarkers

  • von Willebrand factor

  • Total complement hemolytic activity

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved